Extraprostatic Extension Is Extremely Rare for Contemporary Gleason Score 6 Prostate Cancer
| Autor: | Aria Razmaria, Blake B. Anderson, Ximing J. Yang, Gladell P. Paner, Daniel T. Oberlin, Arieh L. Shalhav, Bonnie Choy, Joshua J. Meeks, Gregory P. Zagaja, Scott E. Eggener |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
medicine.medical_specialty Databases Factual Biopsy Urology medicine.medical_treatment 030232 urology & nephrology Gleason Score 6 03 medical and health sciences Prostate cancer 0302 clinical medicine Predictive Value of Tests Prostate medicine Humans Neoplasm Invasiveness Stage (cooking) Aged Neoplasm Staging Chicago Prostatectomy Neoplasm Grading business.industry Incidence (epidemiology) Prostatic Neoplasms Middle Aged medicine.disease medicine.anatomical_structure 030220 oncology & carcinogenesis Cohort business |
| Zdroj: | European Urology. 72:455-460 |
| ISSN: | 0302-2838 |
| DOI: | 10.1016/j.eururo.2016.11.028 |
| Popis: | Background A significant proportion of men with Gleason score 6 (GS6) prostate cancer undergo treatment with radiation or surgery. Objective To assess pathologic stage of pure GS6 at radical prostatectomy (RP). Design, setting, and participants In the period 2003–2014, 7817 patients underwent RP at two institutions. Of 2502 patients with GS6 at surgery, 60 were identified as stage pT3a–b on initial pathologic review, 55 with pT3a (extraprostatic extension, EPE), and five with pT3b (seminal vesicle invasion; SVI). All cases of GS6 with pT3 disease underwent contemporary pathologic evaluation for Gleason grade, stage, and extent of EPE. At one institution, all GS≥7 pT3b cases were re-reviewed for downgrading. The 2014 International Society of Urological Pathology (ISUP) Gleason grading criteria and 2009 ISUP recommendations on pT3 staging were applied. Outcome measurements and statistical analysis Calculated incidence (%) of pT3a, pT3b, pT4, and lymph node-positive disease. Results and limitations Of the 60 GS6 pT3a–b cases identified in the period 2003–2014, seven (0.28% of entire GS6 cohort) with GS6 and pT3a were identified after re-review, all focal EPE. Among the re-examined cohort, no cases of GS6 with pT3b were observed. None of the 132 GS≥7 pT3b cases were downgraded to GS6. Limitations include partial embedding of specimens and separate pathologic review at each institution. Conclusions In a large prostatectomy cohort, GS6 never had seminal vesicle invasion (0%) and was very rarely (0.28%) associated with extraprostatic extension. Patient summary GS6 prostate cancer rarely spreads outside the prostate. A new finding in this study was that GS6 prostate cancer never spread to the seminal vesicles. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect